paxene
norton healthcare ltd. - paclitaxel - sarcoma, kaposi; carcinoma, non-small-cell lung; ovarian neoplasms; breast neoplasms - antineoplastiske midler - paxene er indiceret til behandling af patienter med:• avanceret aids-relateret kaposis sarkom (aids-aa), der har undladt før liposomal antracyklin terapi;• metastatisk karcinom i brystet (mbc), der har svigtet, eller ikke er kandidater til standard antracyklin-holdig terapi;• avanceret ovariecancer (aoc) eller med residual sygdom (> 1 cm) efter indledende laparotomi, i kombination med cisplatin som første-linje-behandling;• metastatisk ovariecancer (moc) efter svigt af platin-med kombinationsbehandling uden taxaner som anden linie behandling.• ikke-småcellet lungekræft (nsclc), der ikke er kandidater til potentielt helbredende operation og/eller strålebehandling i kombination med cisplatin. begrænsede effektivitetsdata understøtter denne indikation (se afsnit 5.
atorvastatin "accord" 10 mg filmovertrukne tabletter
accord healthcare b.v. - atorvastatincalcium (trihydrat) - filmovertrukne tabletter - 10 mg
escitalopram "accord" 10 mg filmovertrukne tabletter
accord healthcare b.v. - escitalopramoxalat - filmovertrukne tabletter - 10 mg
escitalopram "accord" 20 mg filmovertrukne tabletter
accord healthcare b.v. - escitalopramoxalat - filmovertrukne tabletter - 20 mg
escitalopram "accord" 5 mg filmovertrukne tabletter
accord healthcare b.v. - escitalopramoxalat - filmovertrukne tabletter - 5 mg
quetiapin "accord" 100 mg filmovertrukne tabletter
accord healthcare b.v. - quetiapin fumarat - filmovertrukne tabletter - 100 mg
quetiapin "accord" 200 mg filmovertrukne tabletter
accord healthcare b.v. - quetiapin fumarat - filmovertrukne tabletter - 200 mg
quetiapin "accord" 300 mg filmovertrukne tabletter
accord healthcare b.v. - quetiapin fumarat - filmovertrukne tabletter - 300 mg
icatibant accord
accord healthcare s.l.u. - icatibant acetate - angioødemer, arvelige - other hematological agents - icatibant accord is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults, adolescents and children aged 2 years and older, with c1 esterase inhibitor deficiency.
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - multipel sklerose, recidiverende-remitterende - immunosuppressants, selektiv immunosuppressive - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).